Arthritis Market Research Reports & Industry Analysis
Rheumatoid arthritis (RA) is a systemic inflammatory disease. In the United States, approximately a single percent of the population is affected. Women are two to three times more likely to develop rheumatoid arthritis than men, with peak incidence between the fourth and sixth decades. Gender difference disappears in older age. Rheumatoid arthritis affects all races, and its prevalence is not affected by climate. Eighty percent of rheumatoid arthritis patients test rheumatoid factor (RF) positive.
Arthritis Industry Research & Market Reports
-
Global Missouri Medical Cannabis Market Size study, By Product Type (Flower, Oils & Tinctures), By Application (Cancer, Chronic Pain, Arthritis, Diabetes, AIDS, Others), and Regional Forecasts 2022-2028
... USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Missouri medical cannabis is also known as marijuana, which is any strain ... Read More
-
Osteoarthritis Epidemiology Analysis and Forecast, 2021-2031
... of the joints, deterioration of tendons and ligaments, and various degrees of inflammation of the joint lining. OA can occur in more than one region of the body simultaneously and most commonly affects joints in ... Read More
-
Morphine Market: Segmented: by application (Pain Management, Cancer Pain, Neuropathic Pain, Osteoarthritis Pain, Other Pain Management, Diarrhea Suppressant, Cold and Cough Suppressant); by Routine (Oral, Injectables); , And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
... Share & Trends For 2019–2020 And Forecasts To 2031 Morphine Market to surpass USD 57 billion by 2031 from USD 28 billion in 2021 at a CAGR of 7.3% in the coming years, i.e., 2021-31. ... Read More
-
Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treat
... Count, Muscle Enzyme Tests (CPK, Aldolase), Creatinine Test)), By End User (Diagnostic Laboratories, Private Laboratories, Public Laboratories, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - ... Read More
-
Immunology Market, by Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), and Others), by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammat
... Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 ... Read More
-
Autoinjectors Global Market Report 2022 Including: 1) By Type: Disposable Autoinjectors; Reusable Autoinjectors 2) By Therapy: Rheumatoid Arthritis; Multiple Sclerosis; Diabetes; Anaphylaxis; Other Therapies 3) By Route Of Administration: Subcutaneous; Intramuscular 4) By Distribution Channel: Online Retailer; Pharmacy 5) By End User: Home Care Settings; Hospitals And Clinics; Other End Users Covering: AbbVie; Mylan; Eli Lilly and Company; Amgen; Becton, Dickinson and Company; Johnson & Johnson; Teva Pharmaceutical; Merck; Pfizer; Bayer; Biogen; AstraZeneca
... report focuses on autoinjectors market which is experiencing strong growth. The report gives a guide to the autoinjectors market which will be shaping and changing our lives over the next ten years and beyond, including ... Read More
-
Global Osteoarthritis Drugs Market - 2022-2029
... of arthritis, affecting millions of people worldwide. It is a degenerative disease that worsens over time and occurs when the protective cartilage on the person’s bones wears down. The disorder generally affects joints in the ... Read More
-
Gout Disease Treatment Market, by Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Colchicine, Urate-lowering Agents, and Monoclonal Antibody), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital
... and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Gout is the chronic disease characterized by pain and inflammation in ... Read More
-
Chronic Pain Market, by Drug (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, Others), by Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia and Others), by Appli
... by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Chronic pain ... Read More
-
The 2023-2028 World Outlook for Analgesic Osteoarthritis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Arthiritis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Osteoarthritis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Psoriatic Arthritis Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Bioelectric Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Osteoarthritis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Psoriatic Arthritis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Chiropractic Relief Care
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Gout Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Osteoarthritis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Axial Spondyloarthritis Market - A Global and Country Analysis: Focus on Commercialized Therapies, Potential Pipeline Products, Indication, and Country - Analysis and Forecast, 2022-2032
... global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032. The growth in the global axial ... Read More
-
Hydroxychloroquine Market, By Disease Indication (Malaria, Coronavirus Disease, Lupus Erythematosus, and Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin Am
... and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Hydroxychlorquine has exhibits the potential invitro activity against viruses including influenza, malaria, coronavirus, and many other diseases. The drug is under investigation to ... Read More
-
Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2022-2026)
... spanning 2022 to 2026. Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth. However, ... Read More
-
2022 Global: Osteoarthritis Therapeutics - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
Osteoarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore ... Read More
-
Gouty Arthritis (Gout) Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 30 million diagnosed prevalent cases of gout across 16 pharmaceutical markets The majority of marketed drugs for the treatment of gout fall into the enzyme inhibitor and receptor ... Read More
Research Assistance
